应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03320 华润医药
交易中 04-19 09:31:53
4.670
-0.020
-0.43%
最高
4.720
最低
4.650
成交量
10.55万
今开
4.720
昨收
4.690
日振幅
1.49%
总市值
293.39亿
流通市值
293.39亿
总股本
62.83亿
成交额
49.34万
换手率
0.00%
流通股本
62.83亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
华润医药(03320):北京医药建议向华润双鹤转让华润紫竹100%权益的交易已完成
智通财经 · 04-18 18:42
华润医药(03320):北京医药建议向华润双鹤转让华润紫竹100%权益的交易已完成
华润医药04月18日获主力加仓610万元 环比增加380.31%
自选股智能写手 · 04-18 16:15
华润医药04月18日获主力加仓610万元 环比增加380.31%
华润医药商业发行2024年第一期公司债券:规模30亿,利率2.45%-2.63%,期限3-5年,募资用于偿还有息债务
和讯网 · 04-18 03:31
华润医药商业发行2024年第一期公司债券:规模30亿,利率2.45%-2.63%,期限3-5年,募资用于偿还有息债务
华润医药(03320.HK)发公司债募30亿人民币 三年期票息2.45%
阿斯达克财经 · 04-18 00:38
华润医药(03320.HK)发公司债募30亿人民币 三年期票息2.45%
华润医药(03320.HK)附属发行不超30亿元公司债券
格隆汇资讯 · 04-17 19:40
华润医药(03320.HK)附属发行不超30亿元公司债券
华润医药(03320):华润医药商业发行不超过30亿元公司债券
智通财经 · 04-17 19:39
华润医药(03320):华润医药商业发行不超过30亿元公司债券
华润医药(03320.HK)旗下两款药品获药品注册证书
阿斯达克财经 · 04-17 16:29
华润医药(03320.HK)旗下两款药品获药品注册证书
华润医药04月17日主力资金流入127万元 连续3日加仓
自选股智能写手 · 04-17 16:15
华润医药04月17日主力资金流入127万元 连续3日加仓
携重磅产品亮相CMEF,宽腾医疗携手华润医药达成战略合作
挖贝网 · 04-15
携重磅产品亮相CMEF,宽腾医疗携手华润医药达成战略合作
中国航天科技集团与华润医药商业集团医疗器械有限公司签订战略合作协议 共建国产高端医疗装备产业高地
证券时报 · 04-14
中国航天科技集团与华润医药商业集团医疗器械有限公司签订战略合作协议 共建国产高端医疗装备产业高地
华润医药(03320.HK)与华润数科签订2024年信息技术服务采购协议
格隆汇资讯 · 04-12
华润医药(03320.HK)与华润数科签订2024年信息技术服务采购协议
【港股通】华润医药(03320):料东阿阿胶首季溢利3.34亿元-3.57亿元人民币
金吾财讯 · 04-12
【港股通】华润医药(03320):料东阿阿胶首季溢利3.34亿元-3.57亿元人民币
华润医药:东阿阿胶发盈喜 预计第一季度归母净利润约3.34亿至3.57亿元
新浪港股 · 04-12
华润医药:东阿阿胶发盈喜 预计第一季度归母净利润约3.34亿至3.57亿元
华润医药(03320):东阿阿胶(000423.SZ)发盈喜 预计第一季度归母净利润同比增加至约3.34亿-3.57亿元
智通财经 · 04-12
华润医药(03320):东阿阿胶(000423.SZ)发盈喜 预计第一季度归母净利润同比增加至约3.34亿-3.57亿元
华润医药:旗下东阿阿胶2024年第一季度净利润预计达到人民币33,400万至35,700万元
金融界港股 · 04-12
华润医药:旗下东阿阿胶2024年第一季度净利润预计达到人民币33,400万至35,700万元
【券商聚焦】天风证券维持华润医药(03320)“买入”评级 指制药业务快速增长
金吾资讯 · 04-11
【券商聚焦】天风证券维持华润医药(03320)“买入”评级 指制药业务快速增长
北京、广州、珠海集体发力,生物医药产业迎重磅利好
券商中国 · 04-08
北京、广州、珠海集体发力,生物医药产业迎重磅利好
华润医药(03320)上涨5.14%,报4.91元/股
金融界 · 04-08
华润医药(03320)上涨5.14%,报4.91元/股
华润医药盘中异动 早盘急速上涨5.14%
自选股智能写手 · 04-08
华润医药盘中异动 早盘急速上涨5.14%
华润医药盘中异动 快速下跌5.10%报4.821港元
自选股智能写手 · 04-05
华润医药盘中异动 快速下跌5.10%报4.821港元
加载更多
公司概况
公司名称:
华润医药
所属市场:
SEHK
上市日期:
--
主营业务:
华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案,如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。
发行价格:
--
{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":4.67,"timestamp":1713490311924,"preClose":4.69,"halted":0,"volume":105500,"delay":0,"floatShares":6282510461,"shares":6282510461,"eps":0.6621613,"marketStatus":"交易中","marketStatusCode":2,"change":-0.02,"latestTime":"04-19 09:31:53","open":4.72,"high":4.72,"low":4.65,"amount":493365,"amplitude":0.014925,"askPrice":4.68,"askSize":65000,"bidPrice":4.66,"bidSize":17000,"shortable":3,"etf":0,"ttmEps":0.6621612771877056,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1713499200000},"adr":0,"listingDate":1477584000000,"adjPreClose":4.69,"dividendRate":0.035625,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":1.916323,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320","defaultTab":"news","newsList":[{"id":"2428569539","title":"华润医药(03320):北京医药建议向华润双鹤转让华润紫竹100%权益的交易已完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2428569539","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428569539?lang=zh_cn&edition=full","pubTime":"2024-04-18 18:42","pubTimestamp":1713436954,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布公告,于国家市场监督管理总局的相关对口部门的股份转让登记已经完成。因此,截至本公告日期,根据股份转让协议的条款,北京医药建议向华润双鹤转让华润紫竹100%权益的交易已完成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104720.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428551388","title":"华润医药04月18日获主力加仓610万元 环比增加380.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428551388","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428551388?lang=zh_cn&edition=full","pubTime":"2024-04-18 16:15","pubTimestamp":1713428145,"startTime":"0","endTime":"0","summary":"04月18日, 华润医药股价跌1.47%,报收4.69元,成交金额4173万元,换手率0.14%,振幅2.31%,量比1.07。华润医药今日主力资金净流入610万元,连续4日净流入,上一交易日主力净流入127万元,今日环比增加380.31%。该股近5个交易日下跌4.29%,主力资金累计净流入2724万元;近20日主力资金累计净流入2633万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418161616878f0735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418161616878f0735&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428303567","title":"华润医药商业发行2024年第一期公司债券:规模30亿,利率2.45%-2.63%,期限3-5年,募资用于偿还有息债务","url":"https://stock-news.laohu8.com/highlight/detail?id=2428303567","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2428303567?lang=zh_cn&edition=full","pubTime":"2024-04-18 03:31","pubTimestamp":1713382290,"startTime":"0","endTime":"0","summary":" 华润医药近日公布,其旗下华润医药商业已在中国成功发行2024年第一期公司债券。根据公告,募集资金将主要用于偿还有息债务。华润医药作为国内领先的医药企业,其财务状况和资本运作一直受到市场关注。华润医药自成立以来,一直致力于成为中国医药行业的领导者。总体来看,华润医药商业的2024年第一期公司债券发行,是公司资本运作的重要举措。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418070152878bffee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418070152878bffee&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428232685","title":"华润医药(03320.HK)发公司债募30亿人民币 三年期票息2.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428232685","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428232685?lang=zh_cn&edition=full","pubTime":"2024-04-18 00:38","pubTimestamp":1713371880,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布,完成发行2024年第一期公司债券,发行规模不超过30亿人民币,三年期票面利率2.45%,五年期票面利率2.63%。本期募集资金主要用于偿还有息债务。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-17 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190401142438853_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190401142438853_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1343068/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2428112813","title":"华润医药(03320.HK)附属发行不超30亿元公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2428112813","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2428112813?lang=zh_cn&edition=full","pubTime":"2024-04-17 19:40","pubTimestamp":1713354044,"startTime":"0","endTime":"0","summary":"格隆汇4月17日丨华润医药(03320.HK)发布公告,华润医药商业已于中国发行2024年第一期公司债券,发行规模为不超过人民币30亿元,公司债券品种一票面利率为2.45%,期限三年,公司债券品种二票面利率为2.63%,期限五年。本期债券发行所得募集资金将主要用于偿还有息债务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417194051878922f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417194051878922f0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428931900","title":"华润医药(03320):华润医药商业发行不超过30亿元公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2428931900","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428931900?lang=zh_cn&edition=full","pubTime":"2024-04-17 19:39","pubTimestamp":1713353940,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)公布,华润医药商业已于中国发行2024年第一期公司债券,发行规模为不超过人民币30亿元,公司债券品种一票面利率为2.45%,期限三年,公司债券品种二票面利率为2.63%,期限五年。本期债券发行所得募集资金将主要用于偿还有息债务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104072.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428395157","title":"华润医药(03320.HK)旗下两款药品获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2428395157","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428395157?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:29","pubTimestamp":1713342540,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布,旗下华润赛科获得国家药监局颁发的米拉贝隆缓释片《药品注册证书》,并视同通过一致性评价。另外,安徽双鹤获得国家药监局颁发的利奈唑胺葡萄糖注射液《药品注册证书》,并视同通过一致性评价。米拉贝隆缓释片适用于成年膀胱过度活动症患者尿急、尿频或急迫性尿失禁的对症治疗。利奈唑胺葡萄糖注射液主要用于治疗由特定微生物敏感株引起的感染。(ha/cy)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-17 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1343002/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2428938673","title":"华润医药04月17日主力资金流入127万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428938673","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428938673?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:15","pubTimestamp":1713341741,"startTime":"0","endTime":"0","summary":"04月17日, 华润医药股价涨2.37%,报收4.76元,成交金额3508万元,换手率0.12%,振幅3.01%,量比0.95。华润医药今日主力资金净流入127万元,连续3日净流入,上一交易日主力净流入507万元,今日环比减少74.95%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为45.45%,平均涨幅为1.85%。该股近5个交易日下跌2.25%,主力资金累计净流入2083万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入2270万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171616028b2df739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171616028b2df739&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427695042","title":"携重磅产品亮相CMEF,宽腾医疗携手华润医药达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2427695042","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2427695042?lang=zh_cn&edition=full","pubTime":"2024-04-15 15:08","pubTimestamp":1713164895,"startTime":"0","endTime":"0","summary":"今天,一场中国风和医学影像科技的融合演绎在CMEF宽腾医疗展区上演。医学影像综合性平台宽腾医疗携旗下多款重磅产品亮相,并携手华润医药举办了战略合作签约仪式。值得一提的是,活动现场,宽腾医疗还与华润医药签署战略合作协议并举行了签约仪式。宽腾医疗董事长蔡育良表示。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041515120879208414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041515120879208414&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427084883","title":"中国航天科技集团与华润医药商业集团医疗器械有限公司签订战略合作协议 共建国产高端医疗装备产业高地","url":"https://stock-news.laohu8.com/highlight/detail?id=2427084883","media":"证券时报","top":-1,"share":"https://www.laohu8.com/m/news/2427084883?lang=zh_cn&edition=full","pubTime":"2024-04-14 15:48","pubTimestamp":1713080888,"startTime":"0","endTime":"0","summary":"证券时报e公司讯,中国航天科技集团消息,近日,中国航天科技集团有限公司一院北京精密机电控制设备研究所与华润医药商业集团医疗器械有限公司签订了战略合作协议,双方将充分发挥各自优势和资源积累,共同推动国产高端医疗装备产业高地建设。根据合作内容,双方将就医疗器械产品开发、市场营销体系建立等方面积极探索多样化合作模式,使彼此的技术资源、市场资源同频共振,进一步加快技术成果转化,快速建立市场销售渠道,发挥产业资源协同效应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404141548108779a377&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404141548108779a377&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426420043","title":"华润医药(03320.HK)与华润数科签订2024年信息技术服务采购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2426420043","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2426420043?lang=zh_cn&edition=full","pubTime":"2024-04-12 19:01","pubTimestamp":1712919685,"startTime":"0","endTime":"0","summary":"格隆汇4月12日丨华润医药(03320.HK)公告,于2024年4月12日,公司与华润数科签订2024年信息技术服务采购框架协议,据此,集团已同意向华润数科集团采购信息技术服务,期限由2024年4月12日起至2024年12月31日止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412190140876e88a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412190140876e88a9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426243774","title":"【港股通】华润医药(03320):料东阿阿胶首季溢利3.34亿元-3.57亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2426243774","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2426243774?lang=zh_cn&edition=full","pubTime":"2024-04-12 08:48","pubTimestamp":1712882931,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华润医药(03320)公布,于2024年4月11日,附属东阿阿胶公布其截至2024年3月31日止三个月的业绩预告,据此,其公告截至2024年3月31日止三个月归属于东阿阿胶股东的净利润预计约人民币3.34亿元至3.57亿元,扣除非经常性损益后的净利润预计约人民币3.09亿元至3.32亿元及基本每股收益预计约人民币0.52元╱股至约人民币0.55元╱股。","market":"us","thumbnail":"https://static.szfiu.com/news/20200915/NjdlOTQyZDE5NzA3MzU4ZTU3YTk2ZGQ0MjAwMDE4NjcyODIz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NjdlOTQyZDE5NzA3MzU4ZTU3YTk2ZGQ0MjAwMDE4NjcyODIz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1934916","is_publish_highlight":false,"gpt_icon":0},{"id":"2426171032","title":"华润医药:东阿阿胶发盈喜 预计第一季度归母净利润约3.34亿至3.57亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426171032","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2426171032?lang=zh_cn&edition=full","pubTime":"2024-04-12 07:46","pubTimestamp":1712879219,"startTime":"0","endTime":"0","summary":"华润医药(03320)发布东阿阿胶(000423.SZ)截至2024年3月31日止三个月的业绩预告,该集团预计2024年第一季度归属于该集团股东的净利润约3.34亿元(人民币,下同)至3.57亿元(上年同期约2.30亿元)、扣除非经常性损益后的净利润预计约3.09亿元至3.32亿元(上年同期约2.12亿元)及基本每股收益预计约0.52元╱股至约0.55元╱股(上年同期约0.3577元╱股)。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarpmzh7379176.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarpmzh7379176.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426219441","title":"华润医药(03320):东阿阿胶(000423.SZ)发盈喜 预计第一季度归母净利润同比增加至约3.34亿-3.57亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426219441","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426219441?lang=zh_cn&edition=full","pubTime":"2024-04-12 06:22","pubTimestamp":1712874134,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药 发布东阿阿胶截至2024年3月31日止三个月的业绩预告,该集团预计2024年第一季度归属于该集团股东的净利润约3.34亿元至3.57亿元、扣除非经常性损益后的净利润预计约3.09亿元至3.32亿元及基本每股收益预计约0.52元╱股至约0.55元╱股。公告称,2024年,该集团紧紧围绕“增长·质量”发展主题,深化落实“价值重塑、业务重塑、组织重塑、精神重塑”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101438.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426143112","title":"华润医药:旗下东阿阿胶2024年第一季度净利润预计达到人民币33,400万至35,700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426143112","media":"金融界港股","top":-1,"share":"https://www.laohu8.com/m/news/2426143112?lang=zh_cn&edition=full","pubTime":"2024-04-12 06:08","pubTimestamp":1712873289,"startTime":"0","endTime":"0","summary":"金融界4月12日消息,华润医药旗下的东阿阿胶发布了2024年第一季度的业绩预告。预计其净利润将达到人民币33,400万至35,700万元,扣除非经常性损益后的净利润预计约为人民币30,900万至33,200万元。基本每股收益预计约为人民币0.52元至0.55元。华润医药直接持有东阿阿胶9.00%的股权,通过非全资附属公司华润东阿阿胶有限公司持有约23.50%,实际控制东阿阿胶约22.31%的股权。以上数据未经审核,具体财务数据以东阿阿胶将发布的2024年第一季度报告为准。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/12060840206705.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426716285","title":"【券商聚焦】天风证券维持华润医药(03320)“买入”评级 指制药业务快速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2426716285","media":"金吾资讯","top":-1,"share":"https://www.laohu8.com/m/news/2426716285?lang=zh_cn&edition=full","pubTime":"2024-04-11 14:39","pubTimestamp":1712817545,"startTime":"0","endTime":"0","summary":"金吾财讯 | 天风证券发研报指,华润医药 发布2023年年度业绩公告,2023年公司实现营业收入2447.04亿元,同比增长12.2%;实现毛利额383.37亿元,同比增长14.0%;实现归母净利润38.54亿元,同比增长10.1%;实现扣非归母净利润41.90亿元,同比增长21.7%。公司各分部业务增长稳健,制药业务表现亮眼。2024-2025年归母净利润预测由58.06/68.56亿港元下调至47.05/51.56亿港元,2026年归母净利润预测为56.56亿港元;维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111439358765f6e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111439358765f6e7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"1129817395","title":"北京、广州、珠海集体发力,生物医药产业迎重磅利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1129817395","media":"券商中国","top":-1,"share":"https://www.laohu8.com/m/news/1129817395?lang=zh_cn&edition=full","pubTime":"2024-04-08 11:20","pubTimestamp":1712546448,"startTime":"0","endTime":"0","summary":"此次征求意见稿公开征集时间仅3个工作日。在美国生物安全法持续发酵之际,这一利好也能起到较好的对冲作用。北京重磅利好4月7日深夜,北京医保局突然发布创新药重磅利好。由此,三地针对创新药发布的重大利好形成了一个“广东给钱,北京加速”的格局。首先,北京给了不少政策,广东给了不少钱,在这种示范之下,预计后续各地会陆续出台类似的政策利好。","market":"sh","thumbnail":"https://static.tigerbbs.com/9f754e23b0ce9571841146c2a29ecf48","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9f754e23b0ce9571841146c2a29ecf48"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":1},{"id":"2425660087","title":"华润医药(03320)上涨5.14%,报4.91元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425660087","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425660087?lang=zh_cn&edition=full","pubTime":"2024-04-08 10:14","pubTimestamp":1712542475,"startTime":"0","endTime":"0","summary":"4月8日,华润医药(03320)盘中上涨5.14%,截至10:14,报4.91元/股,成交2603.64万元。华润医药集团有限公司是中国的一家综合医药公司,主要业务包括医药研发、制造、分销及零售,旗下拥有多家子公司。2022年,该公司实现营业收入2541.1亿港元,净利润78.4亿港元,位列《财富》中国500强排行榜第65位。截至2023年年报,华润医药营业总收入2447.04亿元、净利润38.54亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/08101440142428.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425079676","title":"华润医药盘中异动 早盘急速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425079676","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425079676?lang=zh_cn&edition=full","pubTime":"2024-04-08 10:04","pubTimestamp":1712541863,"startTime":"0","endTime":"0","summary":"2024年04月08日早盘10时04分,华润医药股票出现波动,股价急速上涨5.14%。截至发稿,该股报4.910港元/股,成交量503.9万股,换手率0.08%,振幅3.85%。华润医药股票所在的药品行业中,整体涨幅为0.12%。其相关个股中,长江生命科技、中国医疗集团、华润医药涨幅较大,振幅较大的相关个股有长江生命科技、三爱健康集团、泰凌医药,振幅分别为12.50%、11.11%、4.55%。华润医药公司简介:华润医药集团有限公司是一家中国香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408100423861e3c59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408100423861e3c59&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425430802","title":"华润医药盘中异动 快速下跌5.10%报4.821港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425430802","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425430802?lang=zh_cn&edition=full","pubTime":"2024-04-05 09:55","pubTimestamp":1712282128,"startTime":"0","endTime":"0","summary":"2024年04月05日早盘09时55分,华润医药股票出现波动,股价急速下挫5.10%。截至发稿,该股报4.821港元/股,成交量273.5万股,换手率0.04%,振幅4.92%。华润医药股票所在的药品行业中,整体跌幅为0.13%。消息层面,截至09时55分,华润医药股票正面舆情新闻比例66.67%。本次卫材中国与华润医药商业、华润三九三方在美能项目上达成合作是业内一个创新之举。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040509552887e7e1ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040509552887e7e1ab&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":-0.0409},{"period":"1month","weight":-0.0676},{"period":"3month","weight":-0.0168},{"period":"6month","weight":0.0152},{"period":"1year","weight":-0.3052},{"period":"ytd","weight":-0.0858}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案,如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.008421},{"month":2,"riseRate":0.75,"avgChangeRate":0.05498},{"month":3,"riseRate":0.5,"avgChangeRate":-0.024129},{"month":4,"riseRate":0.75,"avgChangeRate":0.043546},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.012229},{"month":6,"riseRate":0.428571,"avgChangeRate":0.007002},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.05379},{"month":8,"riseRate":0.428571,"avgChangeRate":0.008896},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.04297},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.027807},{"month":11,"riseRate":0.5,"avgChangeRate":0.023267},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003044}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}